Wearable Tech in the Age of Longevity

Longevity Wearables: Aging Clocks, Hybrid Stacks, Data Moats

'Aging is a disease, and that disease is treatable.'. David Sinclair, Lifespan (2019)

What You'll Learn

• Why does an aging clock validated in Nature beat a $300 blood test for most people?
• How did Oura reach an $11B valuation without ever calling itself medical?
• Why is the prize a decade of healthspan, not a few extra years of life?
• Which predicts death better, a yearly DNA test or 7 days of wrist data?
• Why does the winning model fuse lab tests with wearable data, not either alone?
• Why do the next exits get bought for the dataset, not the device?
• Why will Apple and Samsung ship biological age as a default OS feature?
• How niche hardware wins the categories the giants ignore?
• Who is quietly replacing the annual check-up while nobody's watching?

Why It Matters

The wearable market is projected to grow from $92.9B in 2025 to $230B by 2033 (12.1% CAGR).

Its fastest-growing slice is biological-age tech.

Preventive medicine just moved from the clinic to the wrist.

Problem

Lifespan keeps rising; healthspan doesn't keep pace.

The gold-standard way to measure biological aging, DNA-methylation clocks like Horvath, GrimAge, and DunedinPACE, is precise but slow, costly, and run only a few times a year.

It can't capture the daily swings from stress, travel, poor sleep, or a hard training block.

Your biology changes daily. Your data doesn't.

Solution

A ring reads you around the clock. Sleep, HRV, circadian rhythm, oxygen.

AI turns those signals into a biological age you can move.

No needle. No appointment. No lab.

The output • real-time, behavioral, actionable insight into lowering your biological age.

Players

Wearables turning into longevity platforms

• Oura • $11B valuation, 5.5M rings, ~$1B revenue. Now stacks 50-biomarker blood panels on the ring.
• Whoop • Recovery and strain analytics. Subscription-first near $30/mo.
• Withings • A home station reading dozens of biomarkers.
• RingConn • Continuous HRV, sleep and stress. No subscription.

AI aging-clock models

• Thryve • The plumbing. Normalizes data across Apple, Garmin, and Fitbit.
• AI-PPG Age • Vascular age from a wrist sensor, validated on 212,000 people.
• CosinorAge • Open-source, ETH Zurich. One extra year maps to 8-12% higher mortality.

Longevity hardware

• ARCH • A wearable that simulates walking for desk-bound bodies. TÜBİTAK-backed, at CES 2026.
• Vagustim • Non-invasive vagus-nerve stimulation. In research at Harvard and Duke.

Cellular rejuvenation

• Altos Labs • $3B, Bezos and Milner behind it.
• Retro Biosciences • Altman-backed, chasing a decade of healthspan.

Predictions by Aybars D.

Wearable brands become "aging-clock" ecosystems.

• Apple, Google, and Samsung ship biological age by default, not as a third-party app.

Hybrid platforms dominate.

• A blood test is a photo. A wearable alone is noise. Whoever fuses both owns the trusted score.

Data eats the product and triggers the M&A wave.

• Big Pharma will acquire wearable startups not for hardware dominance, but to access longitudinal biometric datasets required to test and validate senolytic drugs and gene therapies.

Biological Age Becomes a Standard OS Feature

• As research like PpgAge and CosinorAge matures, tech giants (Apple, Google, Samsung) will integrate biological age estimations natively into their operating systems, shifting standard metrics from 'step counts' to "healthspan predictors.

Opportunities

Build for one broken thing.

• Sedentary damage, burnout, autonomic stress. Real markets, no giant defending them.

Be the middleware nobody notices.

• Turn raw device data into a clinician-ready score. Clinics and insurers pay for the signal.

Turn Cities' health-tourism lead into recurring revenue.

• Clinic plus remote monitoring is a subscription, not a procedure.

Risks

• Noise reads as news • A stressful week spikes the score and scares a healthy person.
• The regulator hasn't decided • Aging still isn't a disease on paper. Anything past wellness invites trials.
• Bad numbers leak • Most of this data sits outside HIPAA and KVKK. In an insurer's hands, that's the crisis.

Key Lessons

• Healthspan beats lifespan. Delete the last bad decade. Sell quality of time, not more of it.
• The video beats the photo. A yearly test freezes a moment. A wearable watches the trend, and the trend says more.

Hot Takes

• The annual heart check-up is on borrowed time. A ring reading PPG all day will out-predict an occasional in-clinic ECG, and soon your doctor will want your vascular age before the stethoscope comes out.
• The next trillion-dollar company sells invisible biomarkers. Passive, silent devices read glucose and cellular aging before you ask. The smaller the hardware, the larger the share.

Haters

'Wearables just breed anxiety and the data means nothing.'

True of the first generation. But models like CosinorAge exist to separate signal from noise and surface only what a clinician would act on. The fix for bad data was never no data.

'Real biological age comes from blood and DNA, a ring doing it is marketing.'

Then explain the cohorts. 80,000 for CosinorAge, 212,000 for AI-PPG, both tied to mortality in Nature-family journals. The estimation era is closing. The validated biomarker era has already opened.

Links

1. Cosinorage • The open-source digital biomarker calculating biological age from circadian rhythms.
2. PpgAge via Nature Communications • Deep learning-based estimate of biological age from raw PPG signals.
3. Archtechnology • The ML-powered Wearable Walking Simulator tackling sedentary health risks.
4. Vagustim • Non-invasive Vagus Nerve Stimulation for HRV optimization and stress resilience.
5. A New Generation of Longevity Clinics • The € 2M-backed hybrid clinic model merging wearables with

See you in the next one. To be continued..

Written by Aybars Dorman | July 3, 2026